Bipartisan bill will improve efficiency, predictability at FDA
JC Scott, senior executive vice president, government affairs, for the Advanced Medical Technology Association (AdvaMed), issued the following statement after introduction in the Senate of bipartisan legislation (S.2737) designed to improve the effectiveness of operations at FDA:
“FDA has made great strides in recent years to improve the efficiency, predictability and transparency of its medical technology review process. But we believe that more can be done so that FDA is operating at maximum effectiveness to ensure patients have timely access to medical innovations.